Literature DB >> 8510189

Initial encounters with tobacco cessation on the Inpatient Substance Abuse Unit of the Medical College of Virginia.

L D Karan1.   

Abstract

When the Medical College of Virginia became a smoke-free facility on May 1, 1990, the inpatient unit of the Division of Substance Abuse Medicine decided that it would require tobacco abstinence of its patients, and that it would treat nicotine addiction in a similar fashion as other chemical dependencies. Surreptitious alcohol and drug use on the unit was minimal, but clandestine cigarette smoking prevailed. The succeeding restrictive environment and enforcement efforts became counterproductive. Beginning December 23, 1990, the inpatient unit decided to re-allow smoking. A motivational curriculum for all patients and an optional cessation program for those patients who wish to quit smoking during their inpatient stay is planned. Methods to effectively address nicotine addiction during chemical dependency treatment need to continually be refined and explored.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8510189     DOI: 10.1016/0740-5472(93)90035-z

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  4 in total

1.  Counselors' knowledge of the adoption of tobacco cessation medications in substance abuse treatment programs.

Authors:  Tanja C Rothrauff; Lillian T Eby
Journal:  Am J Addict       Date:  2010-11-12

2.  Varenicline for smoking cessation among methadone-maintained smokers: a randomized clinical trial.

Authors:  M D Stein; C M Caviness; M E Kurth; D Audet; J Olson; B J Anderson
Journal:  Drug Alcohol Depend       Date:  2013-08-14       Impact factor: 4.492

3.  Effects of a tobacco ban on long-term psychiatric patients.

Authors:  Grant T Harris; Daniel Parle; Joseph Gagné
Journal:  J Behav Health Serv Res       Date:  2006-12-19       Impact factor: 1.505

4.  Tobacco use and quit attempts among methadone maintenance clients.

Authors:  K P Richter; C A Gibson; J S Ahluwalia; K H Schmelzle
Journal:  Am J Public Health       Date:  2001-02       Impact factor: 9.308

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.